23431, docket 2026-08552, published May 1, 2026) - removing semaglutide, tirzepatide, and liraglutide from the 503B outsourcing bulks list, with a public comment period through June 2026
Breathe in slowly, filling your lungs and feeling your belly rise beneath your hands
Most patients on a properly structured 36 month protocol notice meaningful changes in body composition, not just the scale
doi: 10.1111/obr.13428 35 WildingJPHBatterhamRLCalannaSDaviesMVan GaalLFLingvayIet al
For those who cannot continue GLP-1 therapy, other FDA-approved anti-obesity medications may be considered
This is why supervised sourcing from a licensed pharmacy matters so much